ERBB3 and breast carcinoma: Prior to laboratory analyses of the prospectively acquired patient biopsy specimens, we evaluated HER3 gene alteration (DNA mutations) in breast cancer patients, using the publicly available bioinformatic database, www.cbioportal.com.